Johnson & Johnson
JNJ
#20
Rank
NZ$863.49 B
Marketcap
NZ$358.40
Share price
-0.93%
Change (1 day)
43.58%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2025 (TTM): NZ$18.06

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$18.13. In 2024 the company made an earnings per share (EPS) of NZ$11.62 a decrease over its 2023 EPS that were of NZ$25.04.

EPS history for Johnson & Johnson from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$18.0655.41%
2024NZ$11.62-53.6%
2023NZ$25.04111.16%
2022NZ$11.86-13.84%
2021NZ$13.7741.81%
2020NZ$9.71-18.92%
2019NZ$11.9721.2%
2018NZ$9.881125.3%
2017NZ$0.81-92.23%
2016NZ$10.377.37%
2015NZ$9.66-4.16%
2014NZ$10.0818.1%
2013NZ$8.5324.88%
2012NZ$6.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.99-83.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.19-27.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.78-29.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$6.44-64.50%๐Ÿ‡ซ๐Ÿ‡ท France
Stryker Corporation
SYK
NZ$13.39-26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.44-64.46%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$35.63 96.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.99-22.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.25-65.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$11.32-37.54%๐Ÿ‡บ๐Ÿ‡ธ USA